22-49884035-T-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_014838.3(ZBED4):​c.373T>A​(p.Phe125Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,453,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

ZBED4
NM_014838.3 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.26

Publications

0 publications found
Variant links:
Genes affected
ZBED4 (HGNC:20721): (zinc finger BED-type containing 4) Enables identical protein binding activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II. Located in cytoplasm and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
ALG12 (HGNC:19358): (ALG12 alpha-1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation. [provided by RefSeq, Jul 2008]
ALG12 Gene-Disease associations (from GenCC):
  • ALG12-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4051095).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZBED4NM_014838.3 linkc.373T>A p.Phe125Ile missense_variant Exon 2 of 2 ENST00000216268.6 NP_055653.2 O75132

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZBED4ENST00000216268.6 linkc.373T>A p.Phe125Ile missense_variant Exon 2 of 2 1 NM_014838.3 ENSP00000216268.4 O75132
ZBED4ENST00000850559.1 linkc.373T>A p.Phe125Ile missense_variant Exon 2 of 2 ENSP00000520851.1
ZBED4ENST00000850560.1 linkn.260+557T>A intron_variant Intron 2 of 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1453768
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
723700
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32722
American (AMR)
AF:
0.00
AC:
0
AN:
41972
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25504
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85772
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53256
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5678
European-Non Finnish (NFE)
AF:
9.01e-7
AC:
1
AN:
1109332
Other (OTH)
AF:
0.00
AC:
0
AN:
59886
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 03, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.373T>A (p.F125I) alteration is located in exon 2 (coding exon 1) of the ZBED4 gene. This alteration results from a T to A substitution at nucleotide position 373, causing the phenylalanine (F) at amino acid position 125 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.057
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
T
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.41
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
N
PhyloP100
7.3
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.21
Sift
Benign
0.081
T
Sift4G
Uncertain
0.038
D
Polyphen
0.99
D
Vest4
0.51
MutPred
0.46
Gain of sheet (P = 0.0344);
MVP
0.10
MPC
1.5
ClinPred
0.76
D
GERP RS
5.3
Varity_R
0.14
gMVP
0.79
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr22-50277683; API